News

AQLANE Medical™ is pleased to announce the first patient has been enrolled and treated in their multicenter clinical trial entitled “The use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial”.

AQLANE Medical™ received approval to start their multicenter clinical trial entitled “The use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial”, in The Netherlands.

AQLANE Medical™ received approval to start their multicenter clinical trial entitled “The use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial”, in Belgium. The University Hospital in Antwerp (UZA) is the first hospital to enroll patients into this 2-year study.

In a recent appearance on The Graham Norton show Kate candidly talked about stress incontinence.

AQLANE Medical™ is pleased to announce the launch of their website www.urolon.com.